1. Home
  2. EUDA vs BRNS Comparison

EUDA vs BRNS Comparison

Compare EUDA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$14.10

Market Cap

24.3M

Sector

Finance

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

HOLD

Current Price

$0.69

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
BRNS
Founded
2021
2016
Country
Singapore
United States
Employees
117
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
24.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EUDA
BRNS
Price
$14.10
$0.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$55.00
$4.00
AVG Volume (30 Days)
325.3K
17.6K
Earning Date
12-19-2023
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$134.73
N/A
Revenue Next Year
$195.03
N/A
P/E Ratio
$123.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.51
52 Week High
$25.70
$2.91

Technical Indicators

Market Signals
Indicator
EUDA
BRNS
Relative Strength Index (RSI) 62.67 64.08
Support Level $1.87 $0.66
Resistance Level $15.36 $0.76
Average True Range (ATR) 4.44 0.05
MACD 0.02 0.01
Stochastic Oscillator 42.03 77.24

Price Performance

Historical Comparison
EUDA
BRNS

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Share on Social Networks: